A novel frailty index improves risk prediction of waitlist mortality over the model for end‐stage liver disease score alone
Heng Fan, Jian‐hua Zhu – 29 January 2018
Direct‐acting antiviral sustained virologic response: Impact on mortality in patients without advanced liver disease
Lisa I. Backus, Pamela S. Belperio, Troy A. Shahoumian, Larry A. Mole – 29 January 2018 – The impact of sustained virologic response (SVR) on mortality after direct‐acting antiviral (DAA) treatment is not well documented in patients without advanced liver disease and affects access to treatment. This study evaluated the impact of SVR achieved with interferon‐free DAA treatment on all‐cause mortality in hepatitis C virus–infected patients without advanced liver disease.
Von Willebrand factor for the liver: Friend or foe?
Qing Pang, Huichun Liu, Hao Jin, Lei Zhou, Zhongran Man – 29 January 2018
Erratum
29 January 2018
Prediction of hepatic encephalopathy: Why disregard well‐known risk factors?
Lorenzo Ridola, Oliviero Riggio – 29 January 2018
Carcinoembryonic antigen‐related cell adhesion molecule 1 controls IL‐2‐dependent regulatory T‐cell induction in immune‐mediated hepatitis in mice
Andrea Kristina Horst, Claudia Wegscheid, Christoph Schaefers, Birgit Schiller, Katrin Neumann, Sebastian Lunemann, Annika E. Langeneckert, Karl J. Oldhafer, Christina Weiler‐Normann, Karl S. Lang, Bernhard B. Singer, Marcus Altfeld, Linda Diehl, Gisa Tiegs – 29 January 2018 – A dysbalance between effector T cells (Tconv) and regulatory T cells (Tregs) and impaired Treg function can cause autoimmune liver disease. Therefore, it is important to identify molecular mechanisms that control Treg homeostasis.
Reply
David Pereyra, Patrick Starlinger – 29 January 2018
Wait‐list mortality of young patients with Biliary atresia: Competing risk analysis of a eurotransplant registry–based cohort
Hubert P. J. van der Doef, Patrick F. van Rheenen, Marieke van Rosmalen, Xavier Rogiers, Henkjan J. Verkade, for pediatric liver transplantation centers of Eurotransplant – 29 January 2018 – Liver transplantation (LT) is the standard treatment for biliary atresia (BA) patients with end‐stage liver disease. The prognosis after LT has steadily improved, but overall prognosis of BA patients is also determined by mortality before LT.
Exploring opportunities to prevent cirrhosis admissions in the emergency department: A multicenter multidisciplinary survey
Shazia Mehmood Siddique, Meghan Lane‐Fall, Matthew J. McConnell, Neha Jakhete, James Crismale, Stefanie Porges, Vandana Khungar, Shivan J. Mehta, David Goldberg, Zhiping Li, Thomas Schiano, Linda Regan, Clinton Orloski, Judy A. Shea – 26 January 2018 – Patients with cirrhosis have high admission and readmission rates, and it is estimated that a quarter are potentially preventable. Little data are available regarding nonmedical factors impacting triage decisions in this patient population.
Khat chewing increases the risk for developing chronic liver disease: A hospital‐based case–control study
Stian Magnus Staurung Orlien, Irene Sandven, Nega Belay Berhe, Nejib Yusuf Ismael, Tekabe Abdosh Ahmed, Kathrine Stene‐Johansen, Svein Gunnar Gundersen, Marsha Yvonne Morgan, Asgeir Johannessen – 25 January 2018 – The chewing of the leaves of Catha edulis (khat) has been implicated in the development of liver disease, but no controlled observations have been undertaken. The objective of the present study was to determine whether khat chewing is associated with development of chronic liver disease (CLD).